Cargando…
Regeneration of T cells from human-induced pluripotent stem cells for CAR-T cell medicated immunotherapy
Background: Chimeric antigen receptor (CAR) T cell treatment involves in vitro production of T cells from patient blood with synthetic receptors specific to a cancer antigen. They circumvent the major histocompatibility complex to recognize the tumor antigen, reducing hematologic malignancy remissio...
Autores principales: | Chen, Yanyan, Huang, Pufeng, Niu, Mengda, Tian, Chuanhuizi, Zhang, Tingting, Peng, Zhiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233047/ https://www.ncbi.nlm.nih.gov/pubmed/37274170 http://dx.doi.org/10.3389/fbioe.2023.1159507 |
Ejemplares similares
-
Evaluation of [(18)F]tetrafluoroborate as a Potential PET Imaging Agent in a Sodium Iodide Symporter-Transfected Cell Line A549 and Endogenous NIS-Expressing Cell Lines MKN45 and K1
por: Niu, Mengda, et al.
Publicado: (2022) -
Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies
por: Mazzola, Marta, et al.
Publicado: (2020) -
N-Acetyl-Cysteine-Loaded Biomimetic Nanofibrous Scaffold for Osteogenesis of Induced-Pluripotent-Stem-Cell-Derived Mesenchymal Stem Cells and Bone Regeneration
por: Li, Xiaolei, et al.
Publicado: (2021) -
Induced pluripotent stem cell-based therapies for organ fibrosis
por: Cheng, Wei, et al.
Publicado: (2023) -
Stem cell homing in periodontal tissue regeneration
por: Meng, Lingxi, et al.
Publicado: (2022)